Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
EYPT:NASDAQ
EyePoint Inc
$13.47
-0.96%
(-0.13) 1D
$13.47
0.00% (0.00)
Pre-market
Closed: Apr 28, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EYPT...
Open
$13.44
High
$13.85
Low
$13.28
Mkt. cap
1.12B
Avg. vol.
1.00M
Volume
864.00
52-wk high
$19.01
52-wk low
$5.30
EPS
-$3.17
Beta
1.89
Shares outstanding
83.43M
No. of employees
214
News stories
From sources across the web
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
24.45M
5.33M
966.00K
620.00K
Cost of goods sold
58.41M
54.65M
47.46M
58.58M
Cost of revenue
58.41M
54.65M
47.46M
58.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.88M
12.91M
15.53M
12.39M
Operating expense
14.88M
12.91M
15.53M
12.39M
Total operating expenses
73.29M
67.56M
62.99M
70.96M
Operating income
-48.84M
-62.23M
-62.02M
-70.34M
Other non operating income
-
-
-
-
EBT including unusual items
-45.20M
-59.33M
-59.73M
-67.42M
EBT excluding unusual items
-45.20M
-59.33M
-59.73M
-67.42M
Income tax expense
-
93.00K
-
186.00K
Effective tax rate
-
-0.16%
-
-0.28%
Other operating expenses
-
-
-
-
Net income
-45.20M
-59.43M
-59.73M
-67.61M
Net profit margin
-184.82%
-1,114.31%
-6,183.44%
-10,904.68%
Earnings per share
-0.65
-0.85
-0.85
-0.81
Interest and investment income
3.64M
2.89M
2.29M
2.96M
Interest expense
-
-
-
-33.00K
Net interest expenses
3.64M
2.89M
2.29M
2.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
-48.34M
-61.69M
-61.45M
-69.65M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer